LOVFF (Cannara Biotech) Other Financing: $-1.81 Mil (TTM As of Feb. 2026)


LOVFF Cannara Biotech Inc LOVFF
84 GF Score
Price $1.18
GF Value $1.18
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cannara Biotech Other Financing?

Cannara Biotech LOVFF -4.84% 84 Other Financing is $-1.81 Mil as of Feb. 2026. GuruFocus rates LOVFF with a GF Score™ of 84/100 and a GF Value™ of $1.18 (Fairly Valued). The stock has 4 warning signs investors should review.

Cannara Biotech's Other Financing for the three months ended in Feb. 2026 was $-0.14 Mil.

Cannara Biotech's Other Financing for the trailing twelve months (TTM) ended in Feb. 2026 was $-1.81 Mil.

Cannara Biotech Other Financing Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech Other Financing Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Other Financing
Get a 7-Day Free Trial -0.90 46.27 -3.40 -2.86 -2.71

Cannara Biotech Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.77 -0.54 -0.71 -0.42 -0.14
LOVFF
84GF Score
Cannara Biotech Inc LOVFF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannara Biotech Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-1.81 Mil mean?
Cannara Biotech (LOVFF) has a Other Financing of $-1.81 Mil as of Feb. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cannara Biotech and its competitors.
Is Cannara Biotech's Other Financing too high?
Cannara Biotech's current Other Financing is $-1.81 Mil. Overall, Cannara Biotech has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's Other Financing compare to ZTS and UTHR?
Cannara Biotech's Other Financing of $-1.81 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cannara Biotech and its competitors. Cannara Biotech's current Other Financing is $-1.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (LOVFF) is currently considered Fairly Valued. The stock's GF Value™ is $1.18, compared to a current price of $1.18 — trading right at its estimated fair value. The current Other Financing is $-1.81 Mil. Cannara Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Cannara Biotech (LOVFF), the current Other Financing is $-1.81 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (LOVFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued. The current stock price of $1.18 is trading 0% below its estimated GF Value™ of $1.18. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for LOVFF:

  • Other Financing: $-1.81 Mil
  • GF Value™: $1.18 vs. price of $1.18 (0% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the LOVFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges 8CB0:GermanyLOVE:Canada
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
84GF Score

Get the complete analysis for LOVFF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.18
Price
$1.18
GF Value